Yiming Pharmaceutical

SZSE · 002826

shenzhen stock exchangeconsumer goods
Market Cap$3.1B
Revenue$670.3M
Employees405
Listed OnSZSE
Ticker002826
CEO / ExecMs. Zhou Min
HeadquartersChengdu
MarketMainland China
Websitewww.emyy.cn

Overview

Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; ethnic medicine products, suitable for treating breast lobular hyperplasia, uterine fibroids, and ovarian cysts; gynecology and obstetrics; and NalMefene hydrochloride injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, severe infection, shock, cord injury,

Data Note

This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.